Advanced in Mononucleosis

Michael P. Pender

Herston, QLD, AU 
Advanced in Mononucleosis
Herston, QLD, AU 
OverviewLocationsClinical Research

Overview

Michael Pender practices in Herston, Australia. Mr. Pender is rated as an Advanced expert by MediFind in the treatment of Mononucleosis. His top areas of expertise are Multiple Sclerosis (MS), Mononucleosis, Pelizaeus-Merzbacher Disease, and Relapsing Multiple Sclerosis (RMS).

His clinical research consists of co-authoring 40 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 14 articles in the study of Mononucleosis.

Gender
Male

Locations

Herston, QLD, Australia
Other Locations
Brisbane, QLD, Australia
Hunter, VIC, Australia
QLD, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 1/2, Two-part, Open-label Dose-escalation and Double-blind, Placebo-controlled Dose-expansion Study With an Open-label Extension to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis
A Phase 1/2, Two-part, Open-label Dose-escalation and Double-blind, Placebo-controlled Dose-expansion Study With an Open-label Extension to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis
Enrollment Status: Terminated
Publish Date: February 23, 2024
Intervention Type: Drug, Biological
Study Drug: ATA188
Study Phase: Phase 1/Phase 2

40 Total Publications

Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020).
Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020).
Journal: Trends in molecular medicine
Published: February 20, 2021

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Pender's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile